Literature DB >> 11136679

Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction.

U Eriksson1, M O Kurrer, R Bingisser, H P Eugster, P Saremaslani, F Follath, S Marsch, U Widmer.   

Abstract

BACKGROUND: Interferon-gamma (IFN-gamma) is an essential cytokine in the regulation of inflammatory responses in autoimmune diseases. Little is known about its role in inflammatory heart disease. METHODS AND
RESULTS: We showed that IFN-gamma receptor-deficient mice (IFN-gammaR(-/-)) on a BALB/c background immunized with a peptide derived from cardiac alpha-myosin heavy chain develop severe myocarditis with high mortality. Although myocarditis subsided in wild-type mice after 3 weeks, IFN-gammaR(-/-) mice showed persistent disease. The persistent inflammation was accompanied by vigorous in vitro CD4 T-cell responses and impaired inducible nitric oxide synthase expression, together with evidence of impaired nitric oxide production in IFN-gammaR(-/-) hearts. Treatment of wild-type mice with the nitric oxide synthetase inhibitor N:-nitro-l-arginine-methyl-ester enhanced in vitro CD4 T-cell proliferation and prevented healing of myocarditis.
CONCLUSIONS: Our data provide evidence that IFN-gamma protects mice from lethal autoimmune myocarditis by inducing the expression of inducible nitric oxide synthase followed by the downregulation of T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136679     DOI: 10.1161/01.cir.103.1.18

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Djahida Bedja; Delisa Fairweather; Yan Wang; Ziya Kaya; Kathleen L Gabrielson; E Rene Rodriguez; Patrizio Caturegli; David A Kass; Noel R Rose
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

2.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

Authors:  M Afanasyeva; Y Wang; Z Kaya; S Park; M J Zilliox; B H Schofield; S L Hill; N R Rose
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 3.  Cardiac Autoimmunity: Myocarditis.

Authors:  William Bracamonte-Baran; Daniela Čiháková
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Regulation of autoimmune myocarditis by host responses to the microbiome.

Authors:  Jobert G Barin; Monica V Talor; Nicola L Diny; SuFey Ong; Julie A Schaub; Elizabeth Gebremariam; Djahida Bedja; Guobao Chen; Hee Sun Choi; Xuezhou Hou; Lei Wu; Ashley B Cardamone; Daniel A Peterson; Noel R Rose; Daniela Čiháková
Journal:  Exp Mol Pathol       Date:  2017-08-16       Impact factor: 3.362

5.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

6.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

7.  CD8alpha dendritic cells and immune protection from experimental allergic encephalomyelitis.

Authors:  A Pettersson; X-C Wu; C Ciumas; H Lian; V Chirsky; Y-M Huang; B Bjelke; H Link; B-G Xiao
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Authors:  Vanessa S Cull; Emmalene J Bartlett; Cassandra M James
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

9.  Oral tolerization with cardiac myosin peptide (614-629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice.

Authors:  Patricia A Gonnella; Pedro J Del Nido; Francis X McGowan
Journal:  J Clin Immunol       Date:  2009-04-08       Impact factor: 8.317

10.  Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis.

Authors:  Gabriel K Griffin; Andrew H Lichtman
Journal:  Circulation       Date:  2013-05-13       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.